Skip to main content
Log in

Recognition and Management of the Cutaneous Manifestations of Celiac Disease

A Guide for Dermatologists

  • Therapy in Practice
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

In celiac disease, the ingestion of gluten-containing cereals, such as wheat, rye, and barley, results in small-bowel mucosal inflammation and villous atrophy with crypt hyperplasia. The prevalence of the condition may be as high as 1% in the adult population. The disease can also embrace various extraintestinal manifestations, of which dermatitis herpetiformis is the best known. Earlier, dermatitis herpetiformis was considered a skin disease occurring often concomitantly with celiac disease. At present, a body of evidence shows that dermatitis herpetiformis is a cutaneous manifestation of celiac disease, and affects approximately 25% of patients with celiac disease. Both conditions can appear in the same family and are closely linked to HLA class II locus in chromosome 6; 90% of patients have HLA DQ2 and, almost all the remainder, HLA DQ8. All patients with dermatitis herpetiformis have at least some-degree of mucosal inflammation or lesion consistent with celiac disease. The etiology of celiac disease in not fully understood, but tissue transglutaminase seems to be the predominant autoantigen both in the intestine and the skin. Serum antibodies against tissue transglutaminase can be used in the serologic screening and follow-up of dietary compliance of patients with celiac disease. Gluten-free diet is essential in the treatment of both conditions, and oral dapsone is usually needed in newly detected dermatitis herpetiformis in order to alleviate symptoms. Oral mucosal lesions, alopecia areata, and vitiligo probably occur more frequently in patients with dermatitis herpetiformis than in the general population. By contrast, the reported association of celiac disease with psoriasis seems to be coincidental.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Fig. 2
Fig. 3
Table II

Similar content being viewed by others

References

  1. Fasano A., Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636–651

    Article  PubMed  CAS  Google Scholar 

  2. Moi H. Incidence and prevalence of dermatitis herpetiformis in a county in central Sweden with comments on the course of the disease and IgA deposits as a diagnostic criterion. Acta Derm Venereol 1984; 64: 144–150

    PubMed  CAS  Google Scholar 

  3. Gawkrodger D.J.G., Blackwell J.N., Gilmour H.K., et al. Dermatitis herpetiformis, diagnosis, diet and demography. Gut 1984; 25: 151–157

    Article  PubMed  CAS  Google Scholar 

  4. Egan C.A., O’Loughlin S., Gormally P., et al. Dermatitis herpetiformis: a review of fifty-four patients. Ir J Med Sci 1997; 166: 241–244

    Article  PubMed  CAS  Google Scholar 

  5. Sigurgeirsson B., Agnarsson B.A., Lindelöf B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994; 308: 13–15

    Article  PubMed  CAS  Google Scholar 

  6. Collin P., Reunala T., Rasmussen M., et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol 1997; 32: 1129–1133

    Article  PubMed  CAS  Google Scholar 

  7. Hall R.P., Clark R.E., Ward F.E. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Acad Dermatol 1990; 22: 436–439

    Article  PubMed  CAS  Google Scholar 

  8. Shibahara M., Nanko H., Shimizu M., et al. Dermatis herpetiformis in Japan: an update. Dermatology 2002; 204: 37–42

    Article  PubMed  CAS  Google Scholar 

  9. Karpati S., Kosnai I., Verkasalo M., et al. HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis. Acta Paediatr Scand 1986; 75: 297–301

    Article  PubMed  CAS  Google Scholar 

  10. Ermacora E., Prampolini L., Tribbia G., et al. Long-term follow-up of dermatitis herpetiformis children. J Am Acad Dermatol 1986; 15: 24–30

    Article  PubMed  CAS  Google Scholar 

  11. Mäki M., Collin P. Coeliac disease. Lancet 1997; 349: 1755–1759

    Article  PubMed  Google Scholar 

  12. Hervonen K., Hakanen M., Kaukinen K., et al. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 2002; 37: 51–55

    Article  PubMed  CAS  Google Scholar 

  13. Meyer L.J., Zone J.J. Familial incidence of dermatitis herpetiformis. J Am Acad Dermatol 1987; 17: 643–647

    Article  PubMed  CAS  Google Scholar 

  14. Lähteenoja H., Irjala K., Viander M., et al. Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol 1998; 134: 756–758

    Article  PubMed  Google Scholar 

  15. Patinen P., Hietanen J., Malmström M., et al. Iodine and gliadin challenge on oral mucosa in dermatitis herpetiformis. Acta Derm Venereol 2002; 82: 86–89

    Article  PubMed  CAS  Google Scholar 

  16. van der Meer R. Granular deposits of immunoglobulins in the skin of the patients with dermatitis herpetiformis. Br J Dermatol 1969; 81: 493–503

    Article  PubMed  Google Scholar 

  17. Zone J.J., Meyer L.J., Petersen M.J. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 1996; 132: 912–918

    Article  PubMed  CAS  Google Scholar 

  18. Beutner E.H., Chorzelski T.B., Reunala T.L., et al. Immunopathology of dermatitis herpetiformis. Clin Dermatol 1992; 9: 295–311

    Article  Google Scholar 

  19. Guide S.V., Marinkovich M.P. Linear IgA bullous dermatosis. Clin Dermatol 2001; 19: 719–727

    Article  PubMed  CAS  Google Scholar 

  20. Alexander J.O. Dermatitis herpetiformis: major problems in dermatology. Vol. 4. London: WB Saunders, 1975

  21. Chorzelski T.P., Jablonska S., Maciejowska E. Linear IgA bullous dermatosis of adults. Clin Dermatol 1992; 9: 383–392

    Article  Google Scholar 

  22. Logan R.F.A., Tucker G., Rifkind E.A., et al. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960–1979. BMJ 1983; 286: 95–97

    Article  PubMed  CAS  Google Scholar 

  23. Reunala T., Kosnai I., Karpati S., et al. Dermatitis herpetiformis: jejunal findings and skin response to gluten-free diet. Arch Dis Child 1984; 59: 517–522

    Article  PubMed  CAS  Google Scholar 

  24. Dieterich W., Ehnis T., Bauer M., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797–801

    Article  PubMed  CAS  Google Scholar 

  25. Lundin K.E.A., Scott H., Hansen T., et al. Gliadin-specific, HLA-DQ (a1*0501, ß1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 87–96

    Article  Google Scholar 

  26. Molberg O., McAdam S.N., Korner R., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713–717

    Article  PubMed  CAS  Google Scholar 

  27. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234–242

    Article  PubMed  CAS  Google Scholar 

  28. Aeschlimann D., Koeller M.K., Allen-Hoffmann B.L., et al. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. J Biol Chem 1998; 273: 3452–3460

    Article  PubMed  CAS  Google Scholar 

  29. Raghunath M., Höpfner B., Aeschlimann D., et al. Cross-linking of the dermoepidermal junction of skin regenerating from keratinocyte aurografts. J Clin Invest 1996; 98: 1174–1184

    Article  PubMed  CAS  Google Scholar 

  30. Sárdy M., Kárpáti S., Merkl B., et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747–757

    Article  PubMed  Google Scholar 

  31. Vogelsang H., Genser D., Wyatt J., et al. Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol 1995; 90: 394–398

    PubMed  CAS  Google Scholar 

  32. Sulkanen S., Collin P., Laurila K., et al. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998; 33: 251–254

    Article  PubMed  CAS  Google Scholar 

  33. Ladinser B., Rossipal E., Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776–778

    Article  PubMed  CAS  Google Scholar 

  34. Dieterich W., Laag E., Schopper H., et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317–1321

    Article  PubMed  CAS  Google Scholar 

  35. Sulkanen S., Halttunen T., Laurila K., et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322–1328

    Article  PubMed  CAS  Google Scholar 

  36. Collin P., Mäki M., Keyriläinen O., et al. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992; 27: 367–371

    Article  PubMed  CAS  Google Scholar 

  37. Dieterich W., Laag E., Bruckner-Tuderman L., et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999; 113: 133–136

    Article  PubMed  CAS  Google Scholar 

  38. Koop I., Ilchmann R., Izzi L., et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000; 95: 2009–2014

    Article  PubMed  CAS  Google Scholar 

  39. Aine L. Permanent tooth dental enamel defects leading to the diagnosis of coeliac disease. Br Dent J 1994; 177: 253–254

    Article  PubMed  CAS  Google Scholar 

  40. Ballinger A., Hughes C., Kumar P., et al. Dental enamel defects in coeliac disease. Lancet 1994; 343: 230–231

    Article  PubMed  CAS  Google Scholar 

  41. Aine L. Coeliac-type permanent tooth enamel defects. Ann Med 1996; 28: 9–12

    Article  PubMed  CAS  Google Scholar 

  42. Hadjivassiliou M., Grunewald R.A., Chattopadhyay A.K., et al. Clinical, radiological, neuropscyhological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352: 1582–1585

    Article  PubMed  CAS  Google Scholar 

  43. Valdimarsson T., Toss G., Ross I., et al. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457–461

    Article  PubMed  CAS  Google Scholar 

  44. Mora S., Barera G., Beccio S., et al. Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol 1999; 94: 398–403

    Article  PubMed  CAS  Google Scholar 

  45. Marsh M.N. Bone disease and gluten sensitivity: time to act, to treat, and to prevent. Am J Gastroenterol 1994; 89: 2105–2107

    PubMed  CAS  Google Scholar 

  46. Reunala T., Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997; 136: 315–318

    Article  PubMed  CAS  Google Scholar 

  47. Zettinig G., Weissel M., Flores J., et al. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto’s thyroiditis. Eur J Clin Invest 2000; 30: 53–57

    Article  PubMed  CAS  Google Scholar 

  48. Cunningham M.J., Zone J.J. Thyroid abnormalities in dermatitis herpetiformis. Ann Intern Med 1985; 102: 194–196

    PubMed  CAS  Google Scholar 

  49. Weetman A.P., Burrin J.M., Mackay D., et al. The prevalence of thyroid autoantibodies in dermatitis herpetiformis. Br J Dermatol 1988; 118: 377–383

    Article  PubMed  CAS  Google Scholar 

  50. Gaspari A.A., Huang C.-M., Davey R.J., et al. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 1990; 88: 145–150

    Article  PubMed  CAS  Google Scholar 

  51. Collin P., Kaukinen K., Välimäki M., et al. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464–483

    Article  PubMed  CAS  Google Scholar 

  52. Fry L., Seah P.P., Riches D.J., et al. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet 1973; I: 288–291

    Article  Google Scholar 

  53. Reunala T., Blomqvist K., Tarpila S., et al. Gluten-free diet in dermatitis herpetiformis: I. clinical response of skin lesions in 81 patients. Br J Dermatol 1977; 97: 473–480

    Article  PubMed  CAS  Google Scholar 

  54. Garioch J.J., Lewis H.M., Sargent S.A., et al. 25 years experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 1994; 131: 541–545

    Article  PubMed  CAS  Google Scholar 

  55. Janatuinen E.K., Pikkarainen P.H., Kemppainen T.A., et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333: 1033–1037

    Article  PubMed  CAS  Google Scholar 

  56. Hardman C.M., Garioch J.J., Leonard J.N., et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337: 1884–1887

    Article  PubMed  CAS  Google Scholar 

  57. Reunala T., Collin P., Holm K., et al. Tolerance to oats in dermatitis herpetiformis. Gut 1998; 43: 490–493

    Article  PubMed  CAS  Google Scholar 

  58. Leonard J.N., Fry L. Treatment and management of dermatitis herpetiformis. Clin Dermatol 1992; 9: 403–408

    Article  Google Scholar 

  59. Collin P., Pukkala E., Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996; 38: 528–530

    Article  PubMed  CAS  Google Scholar 

  60. Leonard J.N., Tucker W.F., Fry J.S., et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 1983; 286: 16–18

    Article  PubMed  CAS  Google Scholar 

  61. Lewis H.M., Reunala T.L., Garioch J.J., et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363–367

    Article  PubMed  CAS  Google Scholar 

  62. Marsden R.A. The treatment of benign bullous dermatosis of childhood, and dermatitis herpetiformis and bullous pemphigoid beginning in childhood. Clin Exp Dermatol 1982; 7 (6): 653–663

    Article  PubMed  CAS  Google Scholar 

  63. Prussick R., Ali M.A.M., Rosenthal D., et al. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis. Arch Dermatol 1992; 128: 210–213

    Article  PubMed  CAS  Google Scholar 

  64. Hörnsten P., Keisu M., Wiholm B.-E. The incidence of agranulosytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Arch Dermatol 1990; 126: 919–922

    Article  PubMed  Google Scholar 

  65. Coleman M.D. Dapsone mediated agranulocytosis: risks, possible mechanism and prevention. Toxicology 2001; 162: 53–60

    Article  PubMed  CAS  Google Scholar 

  66. Kastrup W., Mobacken H., Stockbrugger R., et al. Malbabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anemia. Acta Med Scand 1986; 220: 261–268

    Article  PubMed  CAS  Google Scholar 

  67. Reunala T., Chorzelski T.P., Viander M., et al. IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and antigliadin antibodies. Br J Dermatol 1987; 117: 185–191

    Article  PubMed  CAS  Google Scholar 

  68. Ventura A., Magazzu G., Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297–303

    Article  PubMed  CAS  Google Scholar 

  69. Ferguson R., Basu M.K., Asquith P., et al. Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration. BMJ 1976; 1: 11–13

    Article  PubMed  CAS  Google Scholar 

  70. Ferguson M.M., Wray D., Carmichael H.A., et al. Coeliac disease associated with recurrent aphthae. Gut 1980; 21: 223–226

    Article  PubMed  CAS  Google Scholar 

  71. Wray D. Gluten-sensitive recurrent aphthous stomatitis. Dig Dis Sci 1981; 26: 737–740

    Article  PubMed  CAS  Google Scholar 

  72. Jokinen J., Peters U., Mäki M., et al. Celiac sprue in patients with chronic oral mucosal symptoms. J Clin Gastroenterol 1998; 26: 23–26

    Article  PubMed  CAS  Google Scholar 

  73. Corazza G.R., Andreani M.L., Venturo N., et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology 1995; 109: 1333–1337

    Article  PubMed  CAS  Google Scholar 

  74. Volta U., Bardazzi F., Zauli D., et al. Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol 1997; 136: 801–802

    Article  PubMed  CAS  Google Scholar 

  75. Amato L., Gallerani I., Fuligini A., et al. Dermatitis herpetiformis and vitiligo: report a case and review of literature. J Dermatol 2002; 27: 462–466

    Google Scholar 

  76. de Vos R.J., de Boer W.A., Haas F.D. Is there a relationship between psoriasis and coeliac disease [letter]? J Intern Med 1995; 237: 118

    Article  PubMed  Google Scholar 

  77. Lindqvist U., Rudsander 0.A., Bostrom 0.A., et al. IgA antibodies to gliadin and coeliac disease in psoriatic atrhritis. Rheumatology 2002; 41: 31–37

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Supported by a grant from the Medical Research Fund of Tampere University Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pekka Collin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collin, P., Reunala, T. Recognition and Management of the Cutaneous Manifestations of Celiac Disease. Am J Clin Dermatol 4, 13–20 (2003). https://doi.org/10.2165/00128071-200304010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128071-200304010-00002

Keywords

Navigation